{"cik":1822929,"taxonomy":"us-gaap","tag":"LiabilitiesCurrent","label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","entityName":"Eucrates Biomedical Acquisition Corp.","units":{"USD":[{"end":"2020-09-30","val":237313,"accn":"0001104659-20-132927","fy":2020,"fp":"Q3","form":"10-Q","filed":"2020-12-07","frame":"CY2020Q3I"},{"end":"2021-12-31","val":38460,"accn":"0001410578-22-001827","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-23"},{"end":"2021-12-31","val":38460,"accn":"0001410578-22-002601","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-15"},{"end":"2021-12-31","val":38460,"accn":"0001410578-22-003416","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-14"},{"end":"2021-12-31","val":38460,"accn":"0001410578-23-000637","fy":2022,"fp":"FY","form":"10-K","filed":"2023-04-13","frame":"CY2021Q4I"},{"end":"2022-03-31","val":197192,"accn":"0001410578-22-001827","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-23","frame":"CY2022Q1I"},{"end":"2022-06-30","val":201886,"accn":"0001410578-22-002601","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-15","frame":"CY2022Q2I"},{"end":"2022-09-30","val":119805,"accn":"0001410578-22-003416","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-14","frame":"CY2022Q3I"},{"end":"2022-12-31","val":65140,"accn":"0001410578-23-000637","fy":2022,"fp":"FY","form":"10-K","filed":"2023-04-13","frame":"CY2022Q4I"}]}}